IL51450A - Cefuroxime esters,their preparation and pharmaceutical compositions containing them - Google Patents

Cefuroxime esters,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL51450A
IL51450A IL51450A IL5145077A IL51450A IL 51450 A IL51450 A IL 51450A IL 51450 A IL51450 A IL 51450A IL 5145077 A IL5145077 A IL 5145077A IL 51450 A IL51450 A IL 51450A
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
cefuroxime
esters
Prior art date
Application number
IL51450A
Other languages
English (en)
Other versions
IL51450A0 (en
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27254745&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL51450(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB6009/76A external-priority patent/GB1571683A/en
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of IL51450A0 publication Critical patent/IL51450A0/xx
Publication of IL51450A publication Critical patent/IL51450A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL51450A 1976-02-16 1977-02-15 Cefuroxime esters,their preparation and pharmaceutical compositions containing them IL51450A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB6009/76A GB1571683A (en) 1976-02-16 1976-02-16 Ester derivatives of cefuroxime
GB2730276 1976-06-30
GB2730176 1976-06-30

Publications (2)

Publication Number Publication Date
IL51450A0 IL51450A0 (en) 1977-04-29
IL51450A true IL51450A (en) 1980-11-30

Family

ID=27254745

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51450A IL51450A (en) 1976-02-16 1977-02-15 Cefuroxime esters,their preparation and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US4267320A (xx)
JP (1) JPS52100494A (xx)
AT (1) AT358727B (xx)
AU (1) AU514236B2 (xx)
CA (1) CA1094545A (xx)
CH (2) CH628901A5 (xx)
CY (1) CY1181A (xx)
DE (1) DE2706413C2 (xx)
DK (1) DK149062C (xx)
FR (1) FR2340950A1 (xx)
HK (1) HK17185A (xx)
IL (1) IL51450A (xx)
KE (1) KE3260A (xx)
NL (2) NL185209C (xx)
SE (1) SE431986B (xx)
YU (1) YU40977B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1093549A (en) * 1976-02-16 1981-01-13 Michael Gregson Cephalosporin antibiotics
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
GB1602736A (en) * 1977-08-12 1981-11-18 Glaxo Operations Ltd A-acetoxyethyl esters of 3-carbamoyloxymethyl-7-(2-(fur-2-yl)-2-methoxyiminoacetamido)ceph-3-em-4-carboxylic acids
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
JPS60190783A (ja) * 1983-12-21 1985-09-28 Sumitomo Seiyaku Kk セフエム系化合物
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
GB8810394D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
GB8810393D0 (en) * 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
JPH0586375U (ja) * 1991-07-11 1993-11-22 田中食品機械株式会社 ゴルフ練習用マット
JPH0541572U (ja) * 1991-11-15 1993-06-08 コナミ株式会社 遊戯機器用起伏形成装置
IT1277426B1 (it) * 1995-08-03 1997-11-10 Acs Dobfar Spa Forma cristallina biodisponibile del cefuroxima axetil
CN1111537C (zh) * 1997-05-15 2003-06-18 第一制糖株式会社 高纯晶形头孢呋辛1－乙酰氧乙酯的制备方法
IN186539B (xx) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
EP0937727B1 (de) * 1998-02-20 2002-01-30 Fako Ilaclari A.S. Verfahren zur Herstellung vom löslichen kristallinen Cefuroxim axetil
US6384213B1 (en) 1998-10-23 2002-05-07 Ranbaxy Laboratories Limited Process for preparing a pure, pharmacopoeial grade amorphous form of cefuroxime axetil
WO2000056286A1 (en) 1999-03-19 2000-09-28 Ranbaxy Laboratories Limited Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil
IN190831B (xx) 1999-03-19 2003-08-23 Ranbaxy Lab Ltd
CA2280925A1 (en) 1999-07-29 2001-01-29 Bernard Charles Sherman Stabilized cefuroxime axetil
IN190849B (xx) * 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
AT411996B (de) * 2000-09-11 2004-08-26 Sandoz Ag Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes
JP2004536870A (ja) * 2001-07-25 2004-12-09 ルピン・リミテッド セフロキシムアキセチルの改良された調製方法
ITMI20011763A1 (it) * 2001-08-10 2003-02-10 Antibioticos Spa Processo di preparazione di cefuroxime axelite ad elevata purezza
HRP20020923A2 (en) * 2001-11-23 2003-10-31 Glaxo Group Ltd Pharmaceutical composition
KR100552567B1 (ko) * 2003-08-23 2006-02-15 한국유나이티드제약 주식회사 수분 흡수에 안정하고 빠르게 붕해되는 세푸록심 악세틸을포함하는 정제의 조성물 및 제조 방법
CN1295234C (zh) * 2004-11-15 2007-01-17 中山大学 一种头孢呋辛酯非对映异构体的分离方法
DE102005019458A1 (de) 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
DE102006019619A1 (de) * 2006-04-25 2007-10-31 Grünenthal GmbH Kristalline Modifikation von Cefuroximaxetil
WO2013038323A1 (en) 2011-09-13 2013-03-21 Unimark Remedies Ltd. Taste masked pharmaceutical compositions of cefuroxime axetil
CN111732599A (zh) * 2020-07-08 2020-10-02 江苏正大清江制药有限公司 一种合成头孢呋辛酯二聚体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1310642A (en) 1970-11-09 1973-03-21 Pfizer Alpha-sulfo-and alpha-sulfoalkylacylcephalosporins
US3870713A (en) * 1970-12-07 1975-03-11 Pfizer Phosphono substituted alkylcephalosporins
CA996929A (en) * 1971-04-05 1976-09-14 Kohzi Nakano Acyloxyalkyl ester derivatives of penicillin
US3974153A (en) * 1971-05-14 1976-08-10 Glaxo Laboratories Limited 7-Hydrocarbonoxy imino-acetamido-3-carbamoyloxy methylceph-3-em-4 carboxylic acids
BE794844A (fr) * 1972-02-24 1973-08-01 Pfizer Alpha-carboxy-2-thienylmethylpenicilline et alpha-carboxy-2-thienylmethylcephalosporine,leurs esters et leurs sels
PL98296B1 (pl) 1973-02-07 1978-04-29 Politechnika Gdanskapo Sposob otrzymywania estrow acetoksymetylowych cefalosporyn
US3962227A (en) * 1973-02-23 1976-06-08 Eli Lilly And Company 3-halo cephalosporins
AR207148A1 (es) * 1974-05-02 1976-09-15 Rhone Poulenc Ind Procedimiento para la preparacion de un nuevo derivado de la cefalosporina

Also Published As

Publication number Publication date
SE431986B (sv) 1984-03-12
CY1181A (en) 1983-10-07
NL7701568A (nl) 1977-08-18
NL930073I2 (nl) 1993-11-01
HK17185A (en) 1985-03-22
FR2340950B1 (xx) 1980-02-01
CH634328A5 (de) 1983-01-31
DE2706413C2 (de) 1986-08-28
CA1094545A (en) 1981-01-27
NL185209B (nl) 1989-09-18
IL51450A0 (en) 1977-04-29
JPS633868B2 (xx) 1988-01-26
FR2340950A1 (fr) 1977-09-09
NL185209C (nl) 1990-02-16
KE3260A (en) 1983-03-25
NL930073I1 (nl) 1993-09-16
AU2228877A (en) 1978-08-24
YU40977B (en) 1986-10-31
CH628901A5 (de) 1982-03-31
AT358727B (de) 1980-09-25
SE7701668L (sv) 1977-08-17
ATA100677A (de) 1980-02-15
AU514236B2 (en) 1981-01-29
DE2706413A1 (de) 1977-08-18
JPS52100494A (en) 1977-08-23
YU41177A (en) 1982-06-30
DK149062C (da) 1986-06-16
DK149062B (da) 1986-01-06
DK63877A (da) 1977-08-17
US4267320A (en) 1981-05-12

Similar Documents

Publication Publication Date Title
IL51450A (en) Cefuroxime esters,their preparation and pharmaceutical compositions containing them
ZA771091B (en) Pharmaceutical compositions
ZA774920B (en) Pharmaceutical compositions
IL51660A0 (en) Hentriakontapeptides their preparation and pharmaceutical compositions containing them
PT66622B (en) Pharmaceutical compositions
AU3111677A (en) Pharmaceutical compositions
IL53043A0 (en) Novel 1-aryloxy-2-hydroxy-3-aminopropane - derivatives their preparation and pharmaceutical compositions containing them
NZ186147A (en) Sterolin pharmaceutical compositions
NZ184539A (en) 2-bromo-6-fluoro-n-2-imidazolidinylidene-benzamine pharmaceutical compositions
IL52137A0 (en) Novel aryltrifluoroethylamines their preparation and pharmaceutical compositions containing them
AU2609277A (en) Pharmaceutical compositions
IL60700A0 (en) 25-halocholest-5-ene-2 ,22-diols and esters thereof and pharmaceutical compositions containing them
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
IL53552A (en) 1-piperazinopropanol esters,their preparation and pharmaceutical compositions containing them
IL51468A0 (en) Novel d-homosteroids their preparation and pharmaceutical compositions containing them
AU2574877A (en) Pharmaceutical compositions
GB1547206A (en) Pharmaceutical compositions
ZA772612B (en) Pharmaceutical compositions
IL53026A0 (en) New pyridobenzodiazepinones their preparation and pharmaceutical compositions containing them
IL51451A (en) Cefuroxime esters, their preparation and pharmaceutical compositions containing them
IL52952A (en) Hydroxymethyl-pyridine esters,their preparation and pharmaceutical compositions containing them
IL52006A0 (en) Novel nephthalene derivatives their preparation and pharmaceutical compositions containing them
IL52562A0 (en) Novel cyanoprostaglandins their preparation and pharmaceutical compositions containing them
HK3984A (en) Pharmaceutical compositions
NZ183436A (en) Substituted phenylguanidines and pharmaceutical compositions